EUVIMEDUpptäck EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

NRF2 signalling in cytoprotection and metabolism

Shohei Murakami, Yusuke Kusano, Keito Okazaki, Takaaki Akaike, Hozumi Motohashi iD

British Journal of Pharmacology · 2026-01 · 183 (1) · 101-114

DOI: 10.1111/bph.16246 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, published online on 2023-10-16. Written by Shohei Murakami and 4 co-authors. Institution: Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan. Major MEDLINE topics: NF-E2-Related Factor 2, Signal Transduction, Cytoprotection. Cited 62 times so far (Crossref); 127 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Core Research for Evolutionary Science and Technology, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

The KEAP1 ‐ NRF2 system plays a central role in cytoprotection in defence mechanisms against oxidative stress. The KEAP1‐NRF2 system has been regarded as a sulfur‐utilizing cytoprotective mechanism, because KEAP1 serves as a biosensor for electrophiles by using its reactive thiols and NRF2 is a transcriptional factor regulating genes involved in sulfur‐mediated redox reactions. NRF2 is a key regulator of cytoprotective genes, such as antioxidant and detoxification genes, and also possesses potent anti‐inflammatory activity. Recently NRF2 has been the focus of attention as a regulator of cellular metabolism and mitochondrial function. The NRF2‐mediated regulatory mechanisms of metabolites and mitochondria have been considered diverse, but have not yet been fully clarified. This review article provides an overview of molecular mechanisms that regulate NRF2 signalling and its cytoprotective roles, and highlights NRF2 contribution to cellular metabolism, particularly in the context of mitochondrial function and newly‐found sulfur metabolism. LINKED ARTICLES This article is part of a themed issue Recent Innovations in Targeting Redox Biology for Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.1/issuetoc

Subjects

MeSH terms (MEDLINE)

NF-E2-Related Factor 2Signal TransductionCytoprotectionHumansAnimalsMitochondriaKelch-Like ECH-Associated Protein 1Oxidative Stress

Author keywords

antioxidantmetabolismmitochondriasupersulfide

Substances

NF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1NFE2L2 protein, human

Authors and institutions

  • Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
  • Department of Otolaryngology-Head and Neck Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan.

ORCID profiles: Hozumi Motohashi

Funding

  • Core Research for Evolutionary Science and Technology
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Core Research for Evolutional Science and Technology

Cite

APA

Murakami, S., Kusano, Y., Okazaki, K., Akaike, T., & Motohashi, H. (2026). NRF2 signalling in cytoprotection and metabolism. British Journal of Pharmacology, 183(1), 101-114. https://doi.org/10.1111/bph.16246

Vancouver

Murakami S, Kusano Y, Okazaki K, Akaike T, Motohashi H. NRF2 signalling in cytoprotection and metabolism. British Journal of Pharmacology. 2026;183(1):101-114. doi:10.1111/bph.16246

BibTeX
@article{Murakami2026,
  author = {Murakami, Shohei and Kusano, Yusuke and Okazaki, Keito and Akaike, Takaaki and Motohashi, Hozumi},
  title = {NRF2 signalling in cytoprotection and metabolism},
  journal = {British Journal of Pharmacology},
  year = {2026},
  volume = {183},
  number = {1},
  pages = {101--114},
  doi = {10.1111/bph.16246}
}
Start for free →